ClinConnect ClinConnect Logo
Search / Trial NCT06558318

TMJ Dysfunction: Effects on Proprioception, Pain, and Body Awareness

Launched by NAGIHAN ACET · Aug 14, 2024

Trial Information

Current as of May 29, 2025

Active, not recruiting

Keywords

Joint Position Sense Quantitative Sensory Testing Temporal Summation Cervical Proprioception

ClinConnect Summary

This clinical trial is studying a condition called temporomandibular joint dysfunction (TMJ dysfunction), which affects the jaw joint and the muscles used for chewing. Many people, especially women and young adults aged 20 to 40, experience this issue, which can lead to problems like pain and difficulty with body awareness. The goal of the study is to understand how TMJ dysfunction impacts things like pain sensitivity and the ability to sense where your body is in space, which can be important for everyday activities.

To participate in this study, you need to be between 18 and 25 years old. However, if you have a history of neck injuries, certain chronic pain conditions, or are pregnant, you won't be eligible to join. If you qualify, you can expect to take part in assessments that measure how the TMJ dysfunction affects your pain levels and body awareness. This research is important because it aims to improve the understanding and diagnosis of TMJ dysfunction, which is often overlooked.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \*Being between 18-25 years old
  • Exclusion Criteria:
  • History of cervical spine injuries or disorders
  • Chronic pain conditions or diagnosed musculoskeletal disorders
  • Previous neck or spine surgeries
  • Neurological or psychiatric conditions affecting proprioception or pain perception
  • Use of medications influencing pain sensitivity or proprioception
  • Pregnancy

About Nagihan Acet

Nagihan Acet is a pioneering clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. With a robust portfolio of clinical trials spanning various therapeutic areas, Nagihan Acet emphasizes rigorous scientific methodology and patient-centric approaches. The organization is committed to fostering collaboration with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of safety, efficacy, and ethical conduct in all trial phases. By leveraging cutting-edge technologies and data analytics, Nagihan Acet aims to expedite the development of novel therapies and contribute to the global healthcare landscape.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Nagihan Acet, Phd.

Study Director

Atılım University

Sena Nur Begen, MSc.

Principal Investigator

Atılım University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported